Editorial: Engineered cell-originated biomimetic materials for cancer therapy

Front Bioeng Biotechnol. 2023 Jul 27:11:1259959. doi: 10.3389/fbioe.2023.1259959. eCollection 2023.

Authors

Lan Xiao^{1

2}, Yang Zhang³, Mengya Zhang⁴, Jie Gao⁴

Affiliations

¹ School of Medicine and Dentistry, Griffith University, Gold Coast, QLD, Australia.
² Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia.
³ Nanomedicine and Intestinal Microecology Research Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
⁴ Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China.

No abstract available

Keywords: biomimetic material; cancer immunotherapy; cancer vaccine; cell membrane camouflage; engineered nanoparticles; nanovaccine.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundation of China (82072051).